CAS Number6556-11-2
SynonymsEINECS 229-485-9; Dilcit; 1,2,3,4,5,6-Cyclohexanehexayl hexanicotinate; inositol hexanicotinate; Esantene; Inositol Niacinate; Inositoli nicotinas; Cyclohexane-1,2,3,4,5,6-hexayl hexanicotinate; Dilexpal; MFCD00006387; inositol hexnicotinate; hexa-O-nicotinoyl-myo-inositol; Hexanicotinyl cis-1,2,3,5-trans-4,6-Cyclohexane; Palohex; Linodil; inositol nicotinate; hexanicotinoyl inositol; 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester; Mesotal; Hexanicit; Mesonex; Hexopal; myo-lnositol Hexa-3-pyridinecarboxylate; hexa-3-pyridinecarboxylate; myo-Inositol hexanicotinate; [2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate; Hexa-O-nicotinoyl-myo-inosit; Hexanicotol; Hamovannad; meso-Inositol Hexanicotinate
Molecular FormulaC42H30N6O12
Molecular Weight810.73
Purity98%
Density1.5±0.1 g/cm3
Boiling Point897.0±65.0 °C at 760 mmHg
Melting Point254-256ºC
Appearancewhite powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 6556-11-2 |
| Catalog No. | 2A-9060919 |
| Chinese Name | 肌醇烟酸酯 |
| Synonyms | EINECS 229-485-9; Dilcit; 1,2,3,4,5,6-Cyclohexanehexayl hexanicotinate; inositol hexanicotinate; Esantene; Inositol Niacinate; Inositoli nicotinas; Cyclohexane-1,2,3,4,5,6-hexayl hexanicotinate; Dilexpal; MFCD00006387; inositol hexnicotinate; hexa-O-nicotinoyl-myo-inositol; Hexanicotinyl cis-1,2,3,5-trans-4,6-Cyclohexane; Palohex; Linodil; inositol nicotinate; hexanicotinoyl inositol; 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester; Mesotal; Hexanicit; Mesonex; Hexopal; myo-lnositol Hexa-3-pyridinecarboxylate; hexa-3-pyridinecarboxylate; myo-Inositol hexanicotinate; [2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate; Hexa-O-nicotinoyl-myo-inosit; Hexanicotol; Hamovannad; meso-Inositol Hexanicotinate |
| Molecular Formula | C42H30N6O12 |
| Molecular Weight | 810.73 |
| Purity | 98 |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 897.0±65.0 °C at 760 mmHg |
| Melting Point | 254-256ºC |
| Appearance | white powder |
| Storage Condition | -20℃ |
| Application | Inositol niacin has a vasodilatory effect and is used to study peripheral arterial disease (PAD) [1]. |
| HTC | 2933990090 |
| MDL Number | C42H30N6O12 |
| SMILES | O=C(OC1C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C1OC(=O)c1cccnc1)c1cccnc1 |
| InChI | InChI=1S/C42H30N6O12/c49-37(25-7-1-13-43-19-25)55-31-32(56-38(50)26-8-2-14-44-20-26)34(58-40(52)28-10-4-16-46-22-28)36(60-42(54)30-12-6-18-48-24-30)35(59-41(53)29-11-5-17-47-23-29)33(31)57-39(51)27-9-3-15-45-21-27/h1-24,31-36H |
| InChI Key | MFZCIDXOLLEMOO-UHFFFAOYSA-N |
| MSDS | msds/60919_1_6556_11_2.pdf |
| Bioactivity | Inositol nicotinate, with vasodilatory effect, is used in the study of Peripheral arterial disease (PAD)[1]. Related Catalog Research Areas >> Cardiovascular Disease Signaling Pathways >> Others >> Others References [1]. H Squires, et al. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. NIHR Health Technology Assessment programme: Executive Summaries. Chemical & Physical Properties Density 1.5±0.1 g/cm3 Boiling Point 897.0±65.0 °C at 760 mmHg Melting Point 254-256ºC Molecular Formula C42H30N6O12 Molecular Weight 810.721 Flash Point 496.3±34.3 °C Exact Mass 810.192200 PSA 235.14000 LogP 6.37 Vapour Pressure 0.0±0.3 mmHg at 25°C Index of Refraction 1.675 InChIKey MFZCIDXOLLEMOO-UHFFFAOYSA-N SMILES O=C(OC1C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C1OC(=O)c1cccnc1)c1cccnc1 Storage condition -20℃ |
| Use of | Inositol nicotinate, with vasodilatory effect, is used in the study of Peripheral arterial disease (PAD)[1]. Properties Name inositol hexanicotinate Synonym More Synonyms inositol nicotinate Biological Activity Description Inositol nicotinate, with vasodilatory effect, is used in the study of Peripheral arterial disease (PAD)[1]. Related Catalog Research Areas >> Cardiovascular Disease Signaling Pathways >> Others >> Others References [1]. H Squires, et al. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. NIHR Health Technology Assessment programme: Executive Summaries. Chemical & Physical Properties Molecular Formula C42H30N6O12 Exact Mass 810.192200 PSA 235.14000 Index of Refraction 1.675 InChIKey MFZCIDXOLLEMOO-UHFFFAOYSA-N Storage condition -20℃ |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Nutritional Ingredients | ||
|---|---|---|
| 5,10-methylenetetrahydrofolate | 3432-99-3 | 2A-9060644 |
| Dicethiamine hydrochloride | 616-96-6 | 2A-9060673 |
| LECITHIN ORGANOGEL LIQUID | 2A-152276 | 2A-9060751 |
| FOSMIDOMYCIN, SODIUM SALT | 66508-37-0 | 2A-9060863 |
| L-ARGININE NITRATE HEMIHYDRATE | 2A-152419 | 2A-9060894 |
| BCAA | 5589-96-8 | 2A-9060927 |
| ThiaMine Acetate | 1037-29-2 | 2A-9061295 |
| pyridoxamine | 85-87-0 | 2A-9061338 |
| pyridoxine tripalmitate | 4372-46-7 | 2A-9061374 |
| Sparfosic | 51321-79-0 | 2A-9061381 |
| Browse all Nutritional Ingredients products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS